Blogs about: Kythera Biopharmaceuticals
Featured Blog
Kythera Biopharmaceuticals files for $86 million IPO
Kythera Biopharmaceuticals has filed for an IPO raising about $86 million. The funds will be used to support late stage development and commercialisation of ATX-101, a late-stage obesity therapy. Phas… more →
Silico Research
KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
— 3 comments
wrote 2 months ago: http://clinicaltrials.gov/ct2/show/NCT01426373 The drug is sodium deoxycholate for injection, code-n … more →
Successful IPOs End Languid Stretch, Send Strong Signal to the Market
wrote 7 months ago: Five IPOs, each fetching a price at the top end of their initial estimates, cast an optimistic glow … more →
Kythera Biopharmaceuticals files for $86 million IPO
wrote 1 year ago: Kythera Biopharmaceuticals has filed for an IPO raising about $86 million. The funds will be used to … more →
Kythera Biopharmaceuticals raises $37 milion Series D financing
wrote 1 year ago: Onbiovc.com reports that Kythera Biopharmaceuticals a clinical-stage biopharmaceutical company focus … more →
KYTHERA Biopharmaceuticals partners with Intendis
wrote 2 years ago: KYTHERA Biopharmaceuticals and Intendis, Bayer HealthCare’s dermatology business, have announced tha … more →
